- Report
- February 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- July 2024
- 130 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- August 2024
- 157 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- July 2024
- 230 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 150 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- July 2024
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 53 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- April 2024
- 87 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- November 2024
- 65 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- December 2024
- 150 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2025
- 157 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- June 2024
- 68 Pages
Europe
From €2524EUR$2,655USD£2,120GBP
€2804EUR$2,950USD£2,356GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more